Hiscox Earnings Calls
| Release date | Aug 12, 2026 |
| EPS estimate | $0.749 |
| EPS actual | - |
| Revenue estimate | 2.704B |
| Revenue actual | - |
| Expected change | +/- 0% |
| Release date | Feb 25, 2026 |
| EPS estimate | $0.93 |
| EPS actual | $1.00 |
| EPS Surprise | 6.75% |
| Revenue estimate | 2.379B |
| Revenue actual | 2.059B |
| Revenue Surprise | -13.44% |
| Release date | May 09, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.639 |
| EPS actual | $0.655 |
| EPS Surprise | 2.50% |
| Revenue estimate | 2.908B |
| Revenue actual | 1.841B |
| Revenue Surprise | -36.70% |
Last 4 Quarters for Hiscox
Below you can see how HCXLF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $17.00 |
| EPS estimate | $0.639 |
| EPS actual | $0.655 |
| EPS surprise | 2.50% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $17.00 |
| Aug 01, 2025 | $17.00 |
| Aug 04, 2025 | $17.00 |
| Aug 05, 2025 | $17.00 |
| Aug 06, 2025 | $17.00 |
| Aug 07, 2025 | $17.00 |
| Aug 08, 2025 | $17.00 |
| Aug 11, 2025 | $17.00 |
| Aug 12, 2025 | $17.00 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | May 09, 2025 |
| Price on release | $15.20 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 05, 2025 | $14.78 |
| May 06, 2025 | $14.78 |
| May 07, 2025 | $14.78 |
| May 08, 2025 | $15.20 |
| May 09, 2025 | $15.20 |
| May 12, 2025 | $15.20 |
| May 13, 2025 | $15.20 |
| May 14, 2025 | $15.20 |
| May 15, 2025 | $14.78 |
| 4 days before | 2.84% |
| 4 days after | -2.76% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 25, 2026 |
| Price on release | $20.33 |
| EPS estimate | $0.93 |
| EPS actual | $1.00 |
| EPS surprise | 6.75% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $20.33 |
| Feb 20, 2026 | $20.33 |
| Feb 23, 2026 | $20.33 |
| Feb 24, 2026 | $20.33 |
| Feb 25, 2026 | $20.33 |
| Feb 26, 2026 | $20.33 |
| Feb 27, 2026 | $20.33 |
| Mar 02, 2026 | $20.33 |
| Mar 03, 2026 | $20.33 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Aug 12, 2026 |
| Price on release | - |
| EPS estimate | $0.749 |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $24.50 |
| Aug 05, 2026 | $23.79 |
| Aug 06, 2026 | $23.79 |
| Aug 07, 2026 | $23.79 |
| Aug 10, 2026 | $24.50 |
Hiscox Earnings Call Transcript Summary of Q4 2025
Hiscox reported strong, broad-based 2025 results driven by retail expansion, product innovation and disciplined underwriting across its Retail, London Market and Reinsurance segments. Key metrics: group premiums up $275m (≈6%), undiscounted combined ratio 87.8% (best in a decade), record insurance service result $614m, record investment result $443m, profit before tax $733m, operating RoTE ~21% and 12% growth in book value per share. Retail grew 6.3% (policy growth 7.5%) with a retail combined ratio of 92.6% and management targets 8% retail growth for 2026 and double-digit by 2028. London Market returned to growth with strong underwriting discipline (combined ratio in the 80s); Reinsurance grew selectively (combined ratio in the 60s), with growing third‑party ILS AUM. The change program delivered $29m P&L benefit in 2025 and is on track for $75m in 2026 (targeting $200m by 2028). Capital generation was robust (year-end estimated BSCR 233%; pro forma 211% after buyback/dividend), enabling a 20% step-up in the final dividend and a new $300m share buyback. Management is actively deploying AI across operations and customer/broker portals to drive efficiency and growth, while maintaining a conservative reserving posture (confidence level ~86%). Guidance emphasizes continued retail momentum (8% growth in 2026), disciplined cycle management in big-ticket lines, and ongoing delivery of change-program efficiencies.
Sign In
Buy HCXLF